Mechanisms of resistance to expanded-spectrum beta-lactamases in Escherichia coli isolates recovered in a Spanish hospital.

  1. Briñas, L. 1
  2. Lantero, M. 2
  3. de Diego, I. 2
  4. Alvarez, M. 2
  5. Zarazaga, M. 1
  6. Torres, C. 1
  1. 1 Universidad de La Rioja
    info

    Universidad de La Rioja

    Logroño, España

    ROR https://ror.org/0553yr311

  2. 2 Hospital Universitario Central de Asturias
    info

    Hospital Universitario Central de Asturias

    Oviedo, España

    ROR https://ror.org/03v85ar63

Revista:
Journal of Antimicrobial Chemotherapy

ISSN: 0305-7453

Año de publicación: 2005

Volumen: 56

Número: 6

Páginas: 1107-1110

Tipo: Artículo

beta Ver similares en nube de resultados
DOI: 10.1093/JAC/DKI370 PMID: 16239288 SCOPUS: 2-s2.0-29444449925 WoS: WOS:000233989900018 GOOGLE SCHOLAR

Otras publicaciones en: Journal of Antimicrobial Chemotherapy

Repositorio institucional: lock_openAcceso abierto Editor

Resumen

Objectives: To characterize the β-lactamase genes of the expanded-spectrum cephalosporin-resistant Escherichia coli isolates recovered in a Spanish hospital during the March 2002-March 2003 period. Methods: Thirty-four of the 1700 E. coli isolates recovered from unrela ted patients in a Spanish hospital showed expanded-spectrum cephalosporin resistance. The presence of genes encoding TEM, SHV, CTX-M, CMY-2-type or FOX β-lactamases as well as the existence of mutations in the regulatory region of the chromosomal ampC gene were studied by PCR and sequencing in these 34 E. coli isolates. Results: The following extended-spectrum β-lactamases (ESBLs) or plasmidic class C β-lactamase genes were detected (number of isolates): bla CTX-M-14 (14), bla CTX-M-9 (4), bla CTX-M-32 (1), bla TEM-52 (2), bla SHV-12 (3) and bla CMY-2 (2). The remaining eight isolates showed a mutation in the promoter/attenuator region of the ampC chromosomal gene at position -42, in combination with mutations at positions -18, -1 and +58. The bla TEM-1 gene was also detected in 12 of the ESBL-producing isolates, in both CMY-2-producing isolates and in four of the eight isolates that showed a mutation at position -42 of the ampC promoter. Other mutations in the promoter/attenuator region were detected in association with ESBL or CMY-2 genes, such as the combination -18, -1 and +58, -28 and +58, or +22, +26, +27 and +32. No clonal relationship was found among the CTX-M-producing E. coli isolates by PFGE with Xba I enzyme. Conclusions: Approximately 1.5 % of the E. coli isolates of our hospital harboured ESBL genes, those of the CTX-M-9 group being the most common ones. © The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.